BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/07/2026

Government Owned Invention Available for License: Selective Expansion of Engineered TCR-T Cells for Use in Adoptive Cell Immunotherapy

The National Cancer Institute (NCI) is seeking licensees to commercialize T cell receptor-engineered T cells with hybrid murine/human receptors, which are designed for adoptive cell immunotherapy. These engineered T cells have the potential to selectively expand in the body and target cancer cells.

Source: Federal Register — Health and Human ServicesOpen original release →